Current therapy of chronic myelogenous leukemia

Philip B Mc Glave

Research output: Contribution to journalArticlepeer-review

1 Scopus citations

Abstract

Numerous approaches to CML therapy are now available which promise prolonged remission and, in some cases, cure. What is now needed is a cohesive, integrated and step-wise approach to CML patients providing low-risk therapy when possible, but without jeopardizing the opportunity for cure. Several studies are underway which examine this issue.

Original languageEnglish (US)
Pages (from-to)20-21
Number of pages2
JournalLeukemia and Lymphoma
Volume30
Issue numberSUPPL. 1
StatePublished - Jan 1 1998

Fingerprint Dive into the research topics of 'Current therapy of chronic myelogenous leukemia'. Together they form a unique fingerprint.

Cite this